IMMODULON
LIVE

Serial Number

79252897

Owner

Immodulon Therapeutics Limited

Attorney

Alexandra MacKay

Filing Date

Sep 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

IMMODULON Trademark

Serial Number: 79252897 • Registration: 5946864

IMMODULON is a trademark filed by Immodulon Therapeutics Limited on September 24, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Immodulon Therapeutics Limited (4 trademarks)

475 Salisbury House
London EC2M5QQ , GB

Entity Type: 99

Trademark Details

Filing Date

September 24, 2018

Registration Date

December 31, 2019

Published for Opposition

October 15, 2019

Goods & Services

Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations

Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition

Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of the research and development of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 31, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 8, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 16, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 16, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 31, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 12, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 25, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 25, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2019 NONP
ASSIGNED TO LIE
Sep 12, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2019 TROA
REFUSAL PROCESSED BY IB
Apr 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 21, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 21, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 15, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 13, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 12, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 8, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 28, 2019 REPR